Antion Biosciences SA

Antion Biosciences SA (Antion) is a Swiss biopharmaceutical company developing novel gene and gene-modified cell therapies to treat and cure diseases with significant unmet medical needs. Our proprietary technologies allow for the creation of multimodal treatments that aim to substantially enhance clinical safety and efficacy. We have a number of products in preclinical development, and it is our mission to translate our proprietary technologies into meaningful therapies for the benefit of patients. We are fully committed to creating high-value therapeutic assets, while developing strategies to ensure broad accessibility of our treatments, especially to resource poor communities. Our patent-protected technologies are...

Gene engineering,cell therapy,hiv cure,cancer immunotherapy,sensory disorders,and next generation car t cells

Antion biosciences sa operates in the Biotechnology research industry.

Antion biosciences sa's revenue is 11m - 100m

Antion biosciences sa has 11 - 50 employees.